147 related articles for article (PubMed ID: 33895063)
21. Prevention of ERCP-induced pancreatitis: success at last.
Pasricha P
Gastroenterology; 1997 Apr; 112(4):1415-7. PubMed ID: 9098032
[No Abstract] [Full Text] [Related]
22. Pharmacological prevention of post-ERCP pancreatitis--an everlasting dream?
Hellmig S; Fölsch UR
Dig Liver Dis; 2006 Aug; 38(8):596-8. PubMed ID: 16731061
[No Abstract] [Full Text] [Related]
23. Short-term prophylactic prevention of post-ERCP pancreatitis.
Masci E; Mariani A
Gastrointest Endosc; 2003 Nov; 58(5):816. PubMed ID: 14997914
[No Abstract] [Full Text] [Related]
24. Pharmacological prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
Pande H; Thuluvath P
Drugs; 2003; 63(17):1799-812. PubMed ID: 12921486
[TBL] [Abstract][Full Text] [Related]
25. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy--Italian Group.
Cavallini G; Tittobello A; Frulloni L; Masci E; Mariana A; Di Francesco V
N Engl J Med; 1996 Sep; 335(13):919-23. PubMed ID: 8786777
[TBL] [Abstract][Full Text] [Related]
26. Clinical trial of gabexate in the prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis.
Xiong GS; Wu SM; Zhang XW; Ge ZZ
Braz J Med Biol Res; 2006 Jan; 39(1):85-90. PubMed ID: 16400468
[TBL] [Abstract][Full Text] [Related]
27. Rectal indomethacin or intravenous gabexate mesylate as prophylaxis for acute pancreatitis post-endoscopic retrograde cholangiopancreatography.
Guglielmi V; Tutino M; Guerra V; Giorgio P
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5268-5274. PubMed ID: 29228444
[TBL] [Abstract][Full Text] [Related]
28. Complications of endoscopic sphincterotomy and their prevention.
Huibregtse K
N Engl J Med; 1996 Sep; 335(13):961-3. PubMed ID: 8782505
[No Abstract] [Full Text] [Related]
29. Response to letter to the editor: Appropriate data synthesis provide reliable evidence regarding efficacy of FOY in preventing post endoscopic retrograde cholangiopancreatography pancreatitis.
Kang YN; Chang CC
J Formos Med Assoc; 2021 Sep; 120(9):1798-1799. PubMed ID: 33931292
[No Abstract] [Full Text] [Related]
30. Protease inhibitors for prevention of ERCP pancreatitis: can we afford the price of success?
Ziebert JJ; Bjorkman DJ
Am J Gastroenterol; 1997 Jun; 92(6):1067-8. PubMed ID: 9177543
[No Abstract] [Full Text] [Related]
31. Ulinastatin shows preventive effect on post-endoscopic retrograde cholangiopancreatography pancreatitis in a multicenter prospective randomized study.
Fujishiro H; Adachi K; Imaoka T; Hashimoto T; Kohge N; Moriyama N; Suetsugu H; Kawashima K; Komazawa Y; Ishimura N; Ishihara S; Amano Y; Kinoshita Y
J Gastroenterol Hepatol; 2006 Jun; 21(6):1065-9. PubMed ID: 16724996
[TBL] [Abstract][Full Text] [Related]
32. Prophylaxis of post-ERCP pancreatic complications with gabexate.
Piscaglia F; Righini R; Tewelde AG
Dig Liver Dis; 2007 Mar; 39(3):291; author reply 291. PubMed ID: 17267312
[No Abstract] [Full Text] [Related]
33. Role of ulinastatin in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: the Emperor's New Clothes or Aladdin's Magic Lamp?
Chen S; Shi H; Zou X; Luo H
Pancreas; 2010 Nov; 39(8):1231-7. PubMed ID: 20531245
[TBL] [Abstract][Full Text] [Related]
34. Preventing post-ERCP pancreatitis: where are we?
Testoni PA
JOP; 2003 Jan; 4(1):22-32. PubMed ID: 12555013
[TBL] [Abstract][Full Text] [Related]
35. [Meta-analysis: somatostatin for prophylaxis against post endoscopic retrograde cholangiopancreatography pancreatitis].
Pan SB; Geng XP
Zhonghua Wai Ke Za Zhi; 2016 Jun; 54(6):466-472. PubMed ID: 27938583
[No Abstract] [Full Text] [Related]
36. Pharmacological prevention of post-ERCP pancreatitis: which therapy is best?
Mariani A
JOP; 2003 Jan; 4(1):68-74. PubMed ID: 12555018
[TBL] [Abstract][Full Text] [Related]
37. Frequency of post-ERCP pancreatitis in a single tertiary referral centre without and with routine prophylaxis with gabexate: a 6-year survey and cost-effectiveness analysis.
Testoni PA; Mariani A; Masci E; Curioni S
Dig Liver Dis; 2006 Aug; 38(8):588-95. PubMed ID: 16731060
[TBL] [Abstract][Full Text] [Related]
38. Comparative Efficacy of 9 Major Drugs for Postendoscopic Retrograde Cholangiopancreatography Pancreatitis: A Network Meta-Analysis.
Lyu Y; Wang B; Cheng Y; Xu Y; Du W
Surg Laparosc Endosc Percutan Tech; 2019 Dec; 29(6):426-432. PubMed ID: 31490455
[TBL] [Abstract][Full Text] [Related]
39. Effect of somatostatin on prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis and hyperamylasemia: A systematic review and meta-analysis.
Wang G; Xiao G; Xu L; Qiu P; Li T; Wang X; Wen P; Wen J; Xiao X
Pancreatology; 2018 Jun; 18(4):370-378. PubMed ID: 29550097
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological management of pancreatitis.
Hoogerwerf WA
Curr Opin Pharmacol; 2005 Dec; 5(6):578-82. PubMed ID: 16198632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
